查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830774

2025年胃癌診斷全球市場報告

Gastric Cancer Diagnostic Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，胃癌診斷市場規模呈現強勁成長勢頭，從2024年的25.9億美元成長至2025年的27.8億美元，複合年成長率達7.3%。這段歷史性時期的成長可歸因於幽門螺旋桿菌感染率的上升、人們對胃癌症狀認知的提高、老齡化人口中胃癌發病率的上升、燻製和保存食品消費量的增加，以及高危險群中診斷篩檢應用的增加。

預計未來幾年胃癌診斷市場規模將強勁成長，2029年將達到36.3億美元，複合年成長率為6.9%。預測期內的成長可歸因於對早期檢測和篩檢項目的需求不斷成長、針對胃癌預防的宣傳宣傳活動日益增多、個人化醫療方法的日益普及、新興市場醫療基礎設施的不斷擴展，以及對非侵入性和快速診斷檢測的日益重視。這段時期的主要趨勢包括分子診斷技術的進步、用於提高診斷準確性的生物標記組的開發、攜帶式照護現場診斷設備的開發、微創診斷工具的創新以及成像模式的整合。

胃癌診斷涉及多種測試和程序來檢測和確認胃癌的存在，主要目的是及早發現胃腫瘤，確定腫瘤的類型和階段，並支持有效的治療計劃。

胃癌診斷的主要類型包括內視鏡檢查、影像學檢查、切片檢查、臨床檢測和基於生物標記的檢測。內視鏡檢查需要插入配備攝影機和光源的軟性管，以目視檢查內部器官和組織。這些診斷中使用的產品包括試劑、耗材和儀器，所使用的技術涵蓋分子診斷、免疫檢測測定和次世代定序等。這些診斷方法用於早期檢測、篩檢和疾病監測，服務於廣泛的終端用戶，包括醫院、診所、診斷實驗室和其他醫療機構。

美國關稅的快速上漲以及隨之而來的始於2025年春季的貿易摩擦，對醫療設備行業產生了重大影響，尤其對進口診斷影像設備零件、手術用不銹鋼和塑膠耗材產生了重大影響。醫院和診所抵制漲價，擠壓了製造商的淨利率。監管障礙加劇了這個問題，因為與關稅相關的供應商變更通常需要設備重新認證，從而延緩了產品上市時間。企業正在透過雙重採購關鍵零件、擴大國內商品化生產以及加快具成本效益材料的研發來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供胃癌診斷市場統計數據，例如全球市場規模、區域佔有率、胃癌診斷市場佔有率競爭對手、詳細的胃癌診斷細分市場、市場趨勢和商業機會，以及您在胃癌診斷行業取得成功所需的數據。本胃癌診斷市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

胃癌發生率的上升預計將推動胃癌診斷市場的成長。胃癌是胃黏膜的惡性腫瘤，當細胞不受控制地增生、侵入周圍組織並發生轉移時就會發生。患者數量的增加主要是由於不健康的飲食習慣，包括大量攝取鹽漬、燻製和加工食品，這些食物會損害胃黏膜並增加癌症風險。胃癌診斷有助於早期發現惡性病變，從而及時治療並改善患者預後。提供快速且準確的結果可提高臨床效率並支持更好的疾病管理。例如，美國癌症協會報告稱，2024年5月美國新增胃癌病例26,890例，高於2023年的26,500例，凸顯了對有效診斷解決方案日益成長的需求。

該市場中的公司正在利用人工智慧驅動的內視鏡診斷工具進行創新，以提高早期檢測率和準確性。人工智慧驅動的內視鏡診斷支援設備在內視鏡檢查期間即時分析視訊影像，以檢測胃腸道異常，包括早期癌症。 2024年3月，日本醫療科技公司AI醫療服務株式會社推出了GastroAI-model G，該模型利用深度學習在內視鏡螢幕上突出顯示可疑病變，並立即提醒醫生進行進一步檢查或切片檢查。這項技術創新提高了診斷準確性並實現了早期療育，這對於改善患者預後至關重要。

2025年4月，總部位於丹麥的微生物檢測公司SSI Diagnostica Group收購了墨西哥灣沿岸地區 Scientific Corporation，這是一家專注於幽門螺旋桿菌檢測以檢測胃癌風險的美國診斷公司。此次收購增強了SSI Diagnostica的胃腸道疾病檢測能力，提升了其在美國診斷市場的佔有率，並透過胃癌診斷領域的創新和互補技術來支持其成長。

胃癌診斷市場由提供遺傳諮詢、風險評估計劃、遠距病理諮詢和患者導航服務等服務的營業單位所獲得的收益構成。市場價值還包括服務提供者銷售或包含在其服務產品中的相關產品的價值。胃癌診斷市場還包括液態切片套件、快速診斷測試 (RDT) 設備、數位病理掃描儀、診斷造影和實驗室晶片系統的銷售。該市場的價值是“出廠價”，即產品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場中的產品價值還包括產品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球胃癌診斷：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球胃癌診斷市場：成長率分析
  • 全球胃癌診斷市場表現：規模與成長，2019-2024
  • 全球胃癌診斷市場預測：規模與成長，2024-2029年，2034年
  • 全球胃癌診斷：總目標市場（TAM）

第6章 市場細分

  • 全球胃癌診斷市場（依診斷類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 內視鏡檢查
  • 影像學
  • 切片檢查
  • 實驗室檢查
  • 基於生物標記的測試
  • 全球胃癌診斷市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 試劑和耗材
  • 裝置
  • 全球胃癌診斷市場：依技術、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 分子診斷
  • 免疫檢測
  • 次世代定序
  • 其他技術
  • 全球胃癌診斷市場：應用、績效及預測（2019-2024年、2024-2029年、2034年）
  • 早期診斷
  • 篩檢
  • 監控
  • 全球胃癌診斷市場：按最終用戶、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 診斷實驗室
  • 其他最終用戶
  • 全球胃癌診斷市場：內視鏡細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 常規內視鏡檢查
  • 色鏡學
  • 窄頻成像
  • 共聚焦雷射內視鏡
  • 膠囊內視鏡
  • 全球胃癌診斷市場：依影像（類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 電腦斷層掃描
  • 磁振造影
  • 正子斷層掃描
  • 超音波
  • X光
  • 全球胃癌診斷市場：依切片檢查類型、績效及預測細分，2019-2024 年、2024-2029 年、2034 年
  • 鉗式切片檢查
  • 針吸切片
  • 超音波切片檢查
  • 腹腔鏡切片檢查
  • 全球胃癌診斷市場：依臨床試驗（類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 血液檢查
  • 糞便檢驗
  • 尿素呼氣試驗
  • 血清學
  • 全球胃癌診斷市場：基於生物標記檢測的細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 基因檢測
  • 蛋白質生物標記檢測
  • 循環腫瘤DNA檢測
  • MicroRNA檢測

第7章 區域和國家分析

  • 全球胃癌診斷市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球胃癌診斷市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 胃癌診斷市場：競爭格局
  • 胃癌診斷市場：公司簡介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Agilent Technologies Inc.
  • Illumina Inc.
  • bioMerieux SA
  • Qiagen NV
  • DiaSorin SpA
  • Natera Inc.
  • Myriad Genetics Inc.
  • Fulgent Genetics Inc.
  • Foundation Medicine Inc.
  • Invitae Corporation
  • NeoGenomics Laboratories Inc.
  • Fujirebio Inc.
  • MiRXES Pte Ltd.
  • BIOCEPT Inc.
  • Pillar Biosciences Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年胃癌診斷市場：提供新機會的國家
  • 2029年胃癌診斷市場：細分領域帶來新機會
  • 2029年胃癌診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r37762

Gastric cancer diagnostics encompass a range of tests and procedures designed to detect and confirm the presence of cancer in the stomach. Their primary objective is to identify gastric tumors at an early stage, determine tumor type and progression, and support effective treatment planning.

The primary types of gastric cancer diagnostics include endoscopy, imaging, biopsy, laboratory tests, and biomarker-based testing. Endoscopy involves inserting a flexible tube equipped with a camera and light to visually examine internal organs and tissues. The products used in these diagnostics include reagents, consumables, and instruments, while the technologies employed range from molecular diagnostics and immunoassays to next-generation sequencing and others. These diagnostics are applied for early detection, screening, and disease monitoring, catering to a wide range of end users such as hospitals, clinics, diagnostic laboratories, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The gastric cancer diagnostic market research report is one of a series of new reports from The Business Research Company that provides gastric cancer diagnostic market statistics, including gastric cancer diagnostic industry global market size, regional shares, competitors with a gastric cancer diagnostic market share, detailed gastric cancer diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the gastric cancer diagnostic industry. This gastric cancer diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gastric cancer diagnostic market size has grown strongly in recent years. It will grow from $2.59 billion in 2024 to $2.78 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth during the historic period can be attributed to the rising prevalence of *Helicobacter pylori* infections, increasing awareness of gastric cancer symptoms, higher incidence of gastric cancer among aging populations, greater consumption of smoked and preserved foods, and the expanding use of diagnostic screening in high-risk groups.

The gastric cancer diagnostic market size is expected to see strong growth in the next few years. It will grow to $3.63 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to the increasing demand for early detection and screening programs, rising awareness campaigns focused on gastric cancer prevention, growing adoption of personalized medicine approaches, expansion of healthcare infrastructure in emerging markets, and heightened emphasis on non-invasive and rapid diagnostic tests. Key trends during this period include advancements in molecular diagnostic technologies, development of biomarker panels to enhance diagnostic accuracy, creation of portable point-of-care diagnostic devices, innovation in minimally invasive diagnostic tools, and integration of imaging modalities.

The rising incidence of gastric cancer is expected to drive growth in the gastric cancer diagnostic market. Gastric cancer, a malignant tumor of the stomach lining, develops when cells grow uncontrollably and can invade surrounding tissues or metastasize. The increase in cases is largely attributed to unhealthy dietary habits, including high consumption of salted, smoked, and processed foods, which damage the stomach lining and elevate cancer risk. Gastric cancer diagnostics facilitate early detection of malignant lesions, enabling timely treatment and improved patient outcomes. They enhance clinical efficiency by providing rapid and accurate results that support better disease management. For example, in May 2024, the American Cancer Society reported 26,890 new stomach cancer cases in the U.S., up from 26,500 in 2023, highlighting the growing need for effective diagnostic solutions.

Companies in this market are innovating with AI-powered endoscopic diagnostic tools to improve early detection and accuracy. AI-based endoscopic diagnostic support devices analyze video images in real time during endoscopy to detect gastrointestinal abnormalities, including early-stage cancer. In March 2024, AI Medical Service Inc., a Japan-based medical technology company, launched GastroAI-model G, which uses deep learning to highlight suspicious lesions on the endoscopic screen, alerting physicians instantly for further examination or biopsy. This innovation improves diagnostic accuracy and enables earlier intervention, which is critical for better patient outcomes.

In April 2025, SSI Diagnostica Group, a Denmark-based microbiology company, acquired Gulf Coast Scientific Corporation, a U.S.-based diagnostics firm specializing in H. pylori testing for gastric cancer risk detection. This acquisition strengthens SSI Diagnostica's gastrointestinal disease testing capabilities, enhances its presence in the U.S. diagnostics market, and supports growth through innovation and complementary technology in gastric cancer diagnostics.

Major players in the gastric cancer diagnostic market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMerieux SA, Qiagen N.V., DiaSorin S.p.A, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Foundation Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Fujirebio Inc., MiRXES Pte Ltd., BIOCEPT Inc., Pillar Biosciences Inc.

North America was the largest region in the gastric cancer diagnostic market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gastric cancer diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gastric cancer diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastric cancer diagnostic market consists of revenues earned by entities by providing services such as genetic counselling, risk assessment programmes, telepathology consultations, and patient navigation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastric cancer diagnostics market also includes sales of liquid biopsy kits, rapid diagnostic test (RDT) devices, digital pathology scanners, contrast agents for imaging, and lab-on-a-chip systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastric Cancer Diagnostic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastric cancer diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastric cancer diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastric cancer diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Diagnostic Type: Endoscopy; Imaging; Biopsy; Laboratory Tests; Biomarker-Based Testing
  • 2) By Product: Reagents And Consumables; Instruments
  • 3) By Technology: Molecular Diagnostics; Immunoassays; Next-Generation Sequencing; Other Technologies
  • 4) By Application: Early Diagnosis; Screening; Monitoring
  • 5) By End User: Hospitals; Clinics; Diagnostic Laboratories; Other End Users
  • Subsegments:
  • 1) By Endoscopy: Conventional Endoscopy; Chromoendoscopy; Narrow Band Imaging; Confocal Laser Endomicroscopy; Capsule Endoscopy
  • 2) By Imaging: Computed Tomography; Magnetic Resonance Imaging; Positron Emission Tomography; Ultrasound
  • 3) By Biopsy: Forceps Biopsy; Needle Biopsy; Endoscopic Ultrasound-Guided Biopsy; Laparoscopic Biopsy
  • 4) By Laboratory Tests: Blood Tests; Stool Tests; Urea Breath Test; Serology
  • 5) By Biomarker-Based Testing: Genetic Testing; Protein Biomarker Testing; Circulating Tumor DNA Testing; Microribonucleic Acid Testing
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Becton Dickinson and Company; Quest Diagnostics Incorporated; Agilent Technologies Inc.; Illumina Inc.; bioMerieux SA; Qiagen N.V.; DiaSorin S.p.A; Natera Inc.; Myriad Genetics Inc.; Fulgent Genetics Inc.; Foundation Medicine Inc.; Invitae Corporation; NeoGenomics Laboratories Inc.; Fujirebio Inc.; MiRXES Pte Ltd.; BIOCEPT Inc.; Pillar Biosciences Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gastric Cancer Diagnostic Market Characteristics

3. Gastric Cancer Diagnostic Market Trends And Strategies

4. Gastric Cancer Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Gastric Cancer Diagnostic Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Gastric Cancer Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Gastric Cancer Diagnostic Market Growth Rate Analysis
  • 5.4. Global Gastric Cancer Diagnostic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Gastric Cancer Diagnostic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Gastric Cancer Diagnostic Total Addressable Market (TAM)

6. Gastric Cancer Diagnostic Market Segmentation

  • 6.1. Global Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Endoscopy
  • Imaging
  • Biopsy
  • Laboratory Tests
  • Biomarker-Based Testing
  • 6.2. Global Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents And Consumables
  • Instruments
  • 6.3. Global Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Diagnostics
  • Immunoassays
  • Next-Generation Sequencing
  • Other Technologies
  • 6.4. Global Gastric Cancer Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Early Diagnosis
  • Screening
  • Monitoring
  • 6.5. Global Gastric Cancer Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Other End Users
  • 6.6. Global Gastric Cancer Diagnostic Market, Sub-Segmentation Of Endoscopy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Conventional Endoscopy
  • Chromoendoscopy
  • Narrow Band Imaging
  • Confocal Laser Endomicroscopy
  • Capsule Endoscopy
  • 6.7. Global Gastric Cancer Diagnostic Market, Sub-Segmentation Of Imaging, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Computed Tomography
  • Magnetic Resonance Imaging
  • Positron Emission Tomography
  • Ultrasound
  • X-ray
  • 6.8. Global Gastric Cancer Diagnostic Market, Sub-Segmentation Of Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Forceps Biopsy
  • Needle Biopsy
  • Endoscopic Ultrasound-Guided Biopsy
  • Laparoscopic Biopsy
  • 6.9. Global Gastric Cancer Diagnostic Market, Sub-Segmentation Of Laboratory Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Tests
  • Stool Tests
  • Urea Breath Test
  • Serology
  • 6.10. Global Gastric Cancer Diagnostic Market, Sub-Segmentation Of Biomarker-Based Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genetic Testing
  • Protein Biomarker Testing
  • Circulating Tumor DNA Testing
  • MicroRibonucleic Acid Testing

7. Gastric Cancer Diagnostic Market Regional And Country Analysis

  • 7.1. Global Gastric Cancer Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Gastric Cancer Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gastric Cancer Diagnostic Market

  • 8.1. Asia-Pacific Gastric Cancer Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gastric Cancer Diagnostic Market

  • 9.1. China Gastric Cancer Diagnostic Market Overview
  • 9.2. China Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gastric Cancer Diagnostic Market

  • 10.1. India Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gastric Cancer Diagnostic Market

  • 11.1. Japan Gastric Cancer Diagnostic Market Overview
  • 11.2. Japan Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gastric Cancer Diagnostic Market

  • 12.1. Australia Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gastric Cancer Diagnostic Market

  • 13.1. Indonesia Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gastric Cancer Diagnostic Market

  • 14.1. South Korea Gastric Cancer Diagnostic Market Overview
  • 14.2. South Korea Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gastric Cancer Diagnostic Market

  • 15.1. Western Europe Gastric Cancer Diagnostic Market Overview
  • 15.2. Western Europe Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gastric Cancer Diagnostic Market

  • 16.1. UK Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gastric Cancer Diagnostic Market

  • 17.1. Germany Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gastric Cancer Diagnostic Market

  • 18.1. France Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gastric Cancer Diagnostic Market

  • 19.1. Italy Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gastric Cancer Diagnostic Market

  • 20.1. Spain Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gastric Cancer Diagnostic Market

  • 21.1. Eastern Europe Gastric Cancer Diagnostic Market Overview
  • 21.2. Eastern Europe Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gastric Cancer Diagnostic Market

  • 22.1. Russia Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gastric Cancer Diagnostic Market

  • 23.1. North America Gastric Cancer Diagnostic Market Overview
  • 23.2. North America Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gastric Cancer Diagnostic Market

  • 24.1. USA Gastric Cancer Diagnostic Market Overview
  • 24.2. USA Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gastric Cancer Diagnostic Market

  • 25.1. Canada Gastric Cancer Diagnostic Market Overview
  • 25.2. Canada Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gastric Cancer Diagnostic Market

  • 26.1. South America Gastric Cancer Diagnostic Market Overview
  • 26.2. South America Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gastric Cancer Diagnostic Market

  • 27.1. Brazil Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gastric Cancer Diagnostic Market

  • 28.1. Middle East Gastric Cancer Diagnostic Market Overview
  • 28.2. Middle East Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gastric Cancer Diagnostic Market

  • 29.1. Africa Gastric Cancer Diagnostic Market Overview
  • 29.2. Africa Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gastric Cancer Diagnostic Market Competitive Landscape And Company Profiles

  • 30.1. Gastric Cancer Diagnostic Market Competitive Landscape
  • 30.2. Gastric Cancer Diagnostic Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Gastric Cancer Diagnostic Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. Illumina Inc.
  • 31.3. bioMerieux SA
  • 31.4. Qiagen N.V.
  • 31.5. DiaSorin S.p.A
  • 31.6. Natera Inc.
  • 31.7. Myriad Genetics Inc.
  • 31.8. Fulgent Genetics Inc.
  • 31.9. Foundation Medicine Inc.
  • 31.10. Invitae Corporation
  • 31.11. NeoGenomics Laboratories Inc.
  • 31.12. Fujirebio Inc.
  • 31.13. MiRXES Pte Ltd.
  • 31.14. BIOCEPT Inc.
  • 31.15. Pillar Biosciences Inc.

32. Global Gastric Cancer Diagnostic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gastric Cancer Diagnostic Market

34. Recent Developments In The Gastric Cancer Diagnostic Market

35. Gastric Cancer Diagnostic Market High Potential Countries, Segments and Strategies

  • 35.1 Gastric Cancer Diagnostic Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Gastric Cancer Diagnostic Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Gastric Cancer Diagnostic Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer